Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

计划入组 76 人 · 首次发布于 2019 年 3 月 12 日

Development of the Medicines Optimisation Assessment Tool

计划入组 1,552 人 · 首次发布于 2015 年 10 月 21 日

Use of Homeopathy in Patients Suffering From Long COVID-19

计划入组 15 人 · 首次发布于 2023 年 8 月 21 日

DPP

Glomerulonephritis(Everest Medicines)

Protac (TYK medicines)

Technoderma Medicines, Inc.

China

Blueprint Medicines

United States

3D MEDICINES

Hong Kong, China

Topical JAK/TYK Inhibitor TDM-180935 Shows Promise in Phase 2a Trial for Atopic Dermatitis

Viva Biotech Portfolio Companies Achieve R&D Milestones and Secure Funding

Significant Advances and Collaborations Among Viva's Portfolio Companies